Articles from SANUWAVE Health, Inc.

Q1 2025 revenues were $9.3 million, up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history.

EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM (ET) to present its Q1 2025 financial results.

SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history.

Q4 2024 revenues were $10.3 million, up 47% from Q4 2023. This was an all-time quarterly record for the Company.

SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 21, 2025, at 8:30 AM (ET) to present its Q4 and Full Year 2024 financial results.

SUWANEE, GA / ACCESSWIRE / July 13, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products provided updated dial in instructions for its scheduled conference call on Thursday, July 15th at 4:30pm ET to discuss its recent business activity, provide an update on SEC filings and detail strategic initiatives. Telephone access to the live call will be available by dialing the following numbers: Toll

SUWANEE, GA / ACCESSWIRE / July 8, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products announced it will hold a conference call on Thursday, July 15th at 4:30pm ET to discuss its recent business activity, provide an update on SEC filings and detail strategic initiatives. Telephone access to the live call will be available at 678-578-0113 (in the U.S.). It is recommended that listeners call in at

SUWANEE, GA / ACCESSWIRE / May 27, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, non-invasive

CEO Kevin Richardson to Present Thursday, June 10th, 2021 SUWANEE, GA / ACCESSWIRE / May 26, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products, today announced that management will present at the LD Micro Invitational XI investor conference taking place virtually June 8-10, 2021. Kevin A. Richardson II, Chairman and Chief Executive Officer, is scheduled to host a virtual presentation

SUWANEE, GA / ACCESSWIRE / May 13, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products, has engaged international investor relations specialists MZ Group (MZ) to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with SANUWAVE management to develop and implement a comprehensive capital markets strategy

SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of noninvasive and biological response therapeutics that help expedite the wound healing process at the cellular level, resulting in less time and resources spent on more costly treatments.